The CLSN China deal has a NON-REFUNDABLE "down payment." Whether money from CLSN investors comes in to CTIX, who knows. What will drive CTIX in large part will be the test results.

Let CLSN take care of itself, on its own board.

NOTHING HAS CHANGED in the CTIX story. It has a drug in trials, another shortly to be in trials, great institutions wanting to DO those trials, and terrific animal test results. All for less than 2 bucks a share.